CVS Group Regulatory News (CVSG)

10 April 2018

CVS Group plc

("CVS" or the "Company")

Exercise of Options and Total Voting Rights

CVS, one of the UK's leading providers of integrated veterinary services for small and large animals, announces that 5,168 ordinary shares of 0.2 pence each ("Ordinary Shares") (the "SAYE Shares") were issued on 5 April 2018 as a result of the exercise of employee share options, in connection with the Company's December 2014 - December 2017 (January 2018 Maturity) Save As You Earn Scheme.

The SAYE Shares rank pari passu with all existing Ordinary Shares. The issue of the SAYE Shares has been satisfied via the Company's block listing which was announced on 19 December 2017.

The Company also announces that 790 ordinary shares of 0.2 pence each (the "New Shares") were issued on 5 April 2018 as a result of the exercise of employee share options by a former employee, in connection with the Company's December 2015 - December 2018 (January 2019 Maturity) and December 2016 - December 2019 (January 2020 Maturity) Save As You Earn Schemes.

Application has been made for the New Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, to be admitted to trading on AIM which is expected to occur on or around 16 April 2018.

Following issue of the SAYE Shares and the New Shares, the Company's total issued share capital will consist of 70,320,764 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, following the issue of the New Shares, the total number of voting rights in the Company is 70,320,764. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Contacts: